All articles by Johney

• 

  PPD and Clinical Ink partner on process for lupus assessment

  US contract research organisation PPD and clinical technology company Clinical Ink have jointly developed a systemic lupus erythematosus (SLE) assessment…

• 

  Merck reports data from Phase III KEYNOTE-598 trial

  Merck has reported first-time data from the Phase 3 KEYNOTE-598 trial analysing KEYTRUDA, its anti-PD-1 therapy, along with ipilimumab (Yervoy)…

• 

  Abivax doses first patient in Phase II/III Covid-19 clinical trial

  French biotechnology company Abivax has dosed the first patient in its Phase II/III study of ABX464 in Covid-19 patients at…

• 

  IQVIA and LMC Manna Research to launch Prime Site in Canada

  IQVIA has entered a strategic alliance with LMC Manna Research to launch its first Prime Site for clinical investigation in…

• 

  AES launches patient-transfer programme for biopharma companies

  Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Follow the latest updates of the outbreak on our timeline. Accelerated…